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ABSTRACT
The process of germ cell cyst breakdown and primordial follicle formation that begins
during embryonic development in mammalian ovaries is vital for future reproductive success
because it establishes the total pool of viable egg cells the female will have for the rest of her
life. Germ cells arrive at the gonad in the mouse at approximately 10.5 days post coitum and
begin to form germline cysts through incomplete mitosis. At 13.5 days post coitum, the germ
cells enter meiosis and begin to progress through prophase I of meiosis I. Germ cells progress
through a series of sub-phases of prophase I starting at pre-meiotic interphase and then moving
through leptotene, zygotene, pachytene, and eventually arresting at the diplotene stage. The germ
cells enter diplotene arrest beginning at 17.5 days post coitum, which corresponds with the start
of cyst breakdown. As more germ cells arrive at diplotene and cysts begin to break down to form
primordial follicles, some oocytes experience programmed cell death. The protein MSY2 is
believed to be upregulated at the diplotene stage and therefore could be used as a marker for
diplotene. Through analysis of the MSY2 protein from 15.5 days post coitum through postnatal
day 5 using immunohistochemistry, we were able to see an increase in expression over time. The
increase of expression was expected as our current model suggests that more cells should be
arriving at diplotene as development progresses. Synaptonemal complex protein 3 (SYCP3) has
been shown to be expressed during the pachytene stage of meiotic prophase I and therefore can
be used as a marker for this developmental stage. Analysis of SYCP3 starting at 13.5 days post
coitum through postnatal day 5 using immunohistochemistry showed the greatest percentage of
oocytes in the pachytene stage at postnatal day 1. Exogenous hormone exposure on developing
ovaries can disrupt cyst breakdown and follicle formation, but the process by which the hormone
exposure disrupts the cyst breakdown is not well understood. It is also unclear how hormones

affect progression through prophase I of meiosis. Recreating environments that mimic exogenous
hormone exposure that a female might experience can lead to a better understanding of how
early such exposure can lead to further issues with fertility. To examine the effect or effects of
hormones on meiosis, ovaries were dissected at 17.5 days post coitum and grown in culture for
four days, reaching postnatal day 3, in the presence of 10-6 M estradiol, 10-6 M progesterone,
both 10-6 M estradiol and 10-6 M progesterone, or neither hormone. Ovaries were fixed and
double labeled with MSY2 and oocyte marker TRA98 or SYCP3 and oocyte marker VASA. We
found a decrease in MSY2 expression and an increase in the number of oocytes in the pachytene
stage following hormone treatment, suggesting that estradiol and progesterone can block
progression to the diplotene stage of meiosis. This work will contribute to our understanding of
the effects of hormones on oocyte development by determining if there are any disruptions in
development following the exposure. Information regarding the timing of hormone exposure
with regards to the extent of developmental disruptions will allow for a clearer timeline of when
an individual could experience fertility issues through such exposure.
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Chapter 1: INTRODUCTION
Significance
Infertility in humans is defined as the inability to reproduce by natural means. The ability
of a female to reproduce is essential to the survival of a species. It is vital to understand the
processes that underlie a female’s fertility in order to better the chances of survival for the
species. Not only is it important to comprehend the normal process of reproduction, but it is
crucial to understand why many individuals, both male and female, experience infertility.
Creating this knowledge base can then assure a more fruitful future for that individual. In a
recent poll of the United States, it was found that 7.5 million individual females, between the
ages of 15 – 44, had impaired fecundity (Chandra et al., 2013). Impaired fecundity can mean that
the female may not be able to conceive a child or that she may be able to conceive a child, but
not be able to carry the child full term. There are many potential causes for why a female might
experience this issue including: DNA damage in the oocyte, predisposed genetic issues, or
external environmental factors. Along with these possible fertility complications, females are
also born with a finite number of germ cells that decreases as the female matures and eventually
reaches the period of reproductive senescence (Kim and Tilly, 2004). The number of females
experiencing infertility issues is staggering and the available treatments, such as medication,
surgery, and in vitro fertilization, come with their own difficulties including a high price tag and
no guarantee of improving the fertility of the individual. It is essential that this issue is further
investigated and understood in order to create better treatments that may not only be more cost
effective, but also much less invasive.
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Germ Cell Development in Mammalian Ovaries
For a female to reproduce, proper development of germ cells within the ovary must
occur. This process is tightly regulated to create viable eggs that will have the opportunity to
become fertilized. Starting around 6.5 days post coitum (dpc), or days after mating in mice, a
subset of cells are committed to become germ cells (Saffman and Lasko, 1999). Around 10.5
dpc, the germ cells arrive at the gonad and begin to undergo mitosis and divide rapidly to
increase germ cell numbers (Figure 1) (Peters, 1970). During these divisions, the germ cells are
found in large clusters that synchronously divide and are known as germline cysts (Pepling and
Spradling, 1998). Each germline cyst arises from a single germ cell (Pepling et al., 1999). As
these cells divide, they do not complete cytokinesis and therefore remain connected by
intercellular bridges that may allow for the exchange of important developmental signaling
molecules (Pepling and Spradling, 1998). This division takes place until around 13.5 dpc when
the cells then begin to enter the first of two meiotic divisions.
Starting at 13.5 dpc, the germ cells enter prophase I of meiosis I. The cells complete premeiotic interphase and progress through leptotene, zygotene, pachytene, and diplotene stages
(Pepling, 2006). This process occurs in a wave starting from the anterior end of the ovary to the
posterior end (Borum, 1961; Menke et al., 2003). Once the diplotene stage is reached, the germ
cells arrest and remain arrested until further signals are produced, typically after puberty, that
allow the cell to be released and developed into a mature egg cell that is ready to be fertilized.
Oocytes begin to arrest at diplotene around 17.5 dpc and the process continues as more germ
cells progress through meiosis. At about PND5 almost all oocytes are arrested at the diplotene
stage.
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Figure 1
Timeline of mouse germ cell development. Germ cells are shown in green and somatic cells
are shown in red. At 10.5 dpc, germ cells migrate to the gonad and begin rapidly dividing
through mitosis, forming cysts. Beginning at 13.5 dpc, mitosis stops and germ cells begin to
enter meiotic prophase I. Oocytes continue through meiosis progressing through leptotene,
zygotene, pachytene, and diplotene stages. The oocytes arrive and begin to arrest at the
diplotene stage at 17.5 dpc. At this time, germline cysts begin to breakdown and germ cells
that are not lost due to apoptosis are surrounded by somatic cells forming primordial follicles.
(Adapted from Pepling, 2006)
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Follicle Formation and Cyst Breakdown
For primordial follicles to form within the ovary, germline cyst breakdown must occur. A
primordial follicle is a single germ cell surrounded by a single layer of somatic cells, called
granulosa cells. The somatic cells move between germ cells within cysts and are believed to play
a role in separating the cells (Pepling and Spradling, 2001). Along with the somatic cells moving
between germ cells and breaking apart the germline cysts, apoptosis of germ cells also plays a
crucial role in the cyst breakdown and follicle formation process (Coucouvanis et al., 1993;
Pepling and Spradling, 2001). The loss of germ cells through programmed cell death correlates
with primordial follicle formation (Greenfeld et al., 2007; Pepling and Spradling, 2001). The
surviving germ cells that progress into primordial follicles then establish the total pool of germ
cells the female will have for their whole reproductive lifespan.

Effects of Hormones on Meiotic Progression and Cyst Breakdown
The process of germ cells dividing through mitosis and forming germline cysts prior to
entering meiosis has been extensively studied and well documented in the field. From that
knowledge base, further investigation into meiotic progression and cyst breakdown was
conducted and it was hypothesized that germ cells remain in cysts due to hormone exposure from
the mother and the cysts begin to breakdown at birth once the hormone levels significantly drop.
Thus, contexts where sustained elevated hormones prevail may lead to serious defects in ovarian
development.
Studies to investigate the effects of estrogens on cyst breakdown and follicle formation
have been done both in vivo and in vitro using varying concentrations of estradiol, one of the
mammalian estrogens (Figure 2) (Chen et al., 2007). Ovaries from neonatal pups injected with
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estradiol and ovaries grown in an organ culture system with the addition of estradiol both
showed a significant disruption in cyst breakdown and significantly fewer follicles that were also
developmentally delayed (Chen et al., 2007). This agrees with previous studies that investigated
the role of estrogens through the exposure of genistein, a soybean phytoestrogen, which has
estrogenic activity that disrupted cyst breakdown and follicle formation (Jefferson et al., 2006).
Along with the disruption of cyst breakdown, estrogen has also been shown to induce multiple
oocyte follicles (MOFs) in adult ovaries which are mature follicles containing more than one
germ cell, thought to be the result of cysts that never broke down (Iguchi et al., 2001). The
genistein exposure also produced the same result, confirming the estrogen effect of promoting
the production of MOFs (Jefferson et al., 2002). These MOFs are less viable than single oocyte
follicles due to improper breakdown of the cyst. The method by which estrogen can cause these
effects has been further investigated, and it has been shown that there are multiple pathways by
which estrogen can signal to the oocyte through the use of multiple estrogen receptors (Chen et
al., 2009).
Progesterone has also been shown to have a negative effect on ovarian development
through the disruption of cyst breakdown and follicle formation (Chen et al., 2007). Ovaries
grown in an organ culture system with the addition of progesterone or estradiol + progesterone
also had a disruption of cyst breakdown and a delay in follicle development (Chen et al., 2007).
Recently, the receptor by which progesterone acts, progesterone receptor membrane component
1 (PGRMC1), to disrupt cyst breakdown and follicle formation was discovered (Guo et al.,
2016). It was also shown that progesterone acts via PGRMC1 to suppress oocyte progression
through meiotic prophase I.
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Further investigation showed that there is actually a decrease in maternal progesterone
levels prior to birth, which initiates cyst breakdown at an earlier time point, but the maternal
estrogen levels remain high, which maintains some cysts (Dutta et al., 2014). It was also shown
that the fetal ovary has its own source of hormones that assists in the regulation of cyst
breakdown and follicle formation (Dutta et al., 2014). In either case, it is clear that the hormone
exposure on the developing germ cells has an effect and is causing the oocytes to remain in cysts.

Figure 2
Model for cyst breakdown and estrogen signaling. Timeline shows normal cyst breakdown on
top and cyst breakdown being affected by estrogen treatment on the bottom. After birth,
estrogen levels fall and cyst breakdown can occur. When additional estrogen is introduced,
cyst breakdown is disrupted and follicle formation is delayed. (Adapted from Jefferson et al.,
2006)
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MSY2 Expression in the Ovary
The Y-Box protein MSY2 is a member of the Y box multigene family of nucleic acid
binding proteins (Gu et al., 1998). MSY2 is specifically expressed in both male and female germ
cells and has also been shown to be maternally inherited (Gu et al., 1998). Expression of MSY2
is localized to the cytoplasm of germ cells and has a temporal expression pattern which suggests
a function of storage and translation of mRNAs (Gu et al., 1998). Also MSY2 is very abundant
within the oocyte and makes up about 2% of total oocyte protein (Yu et al., 2001). The protein is
believed to be involved in regulating global stability of mRNA and when the gene is deleted,
females become sterile (Yang et al., 2005). It has been shown in several studies that when there
is a loss of MSY2 expression within an organism, the individual becomes infertile and different
phenotypic changes are observed, such as decreased folliculogenesis and a reduction in oocyte
number (Medvedev et al., 2011).
Within the field of reproduction, MSY2 has been widely used as a marker for diplotene
arrest of oocytes progressing through meiotic prophase I (Paredes et al., 2005). Therefore,
characterizing MSY2 using immunohistochemistry could provide insight into the regulation of
early oocyte development. Also, questions such as which pathways regulate meiotic prophase I
progression and how environmental factors might disrupt this process can then be addressed.

SYCP3 Expression in the Ovary
Synaptonemal complexes (SCs) are structures formed between homologous
chromosomes during the pachytene stage of meiotic prophase and are involved with
chromosome pairing and recombination (Meuwissen et al., 1992). There have been three
isoforms of SC proteins (SYCPs), SYCP1, SYCP2, and SYCP3 (also known as SCP1, SCP2,
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and SCP3) that have been identified in mammals (Lammers et al., 1994; Meuwissen et al., 1992;
Offenberg et al., 1998). These SCs contain two proteinaceous axes, lateral elements (LEs) found
along each homologue and transverse filaments (TFs) that connect LEs (Lammers et al., 1994;
Meuwissen et al., 1997). Mutant forms of SC components can lead to chromosome instabilities
which, in turn, can produce a number of different problems, including cancer. A mutation in
SYCP3 specifically was shown to lead to reproductive problems in people (Lopez-Carrasco et
al., 2013).
SYCP3, in particular, has been observed to be located in lateral elements of SCs
specifically (Ollinger et al., 2005). The expression of SYCP3 mRNA has been detected in
primordial germ cells (PCGs), pre-meiotic germ cells and meiotic prophase I oocytes (Zheng et
al., 2009). The expression pattern of SYCP3 protein is distinct within meiotic prophase I oocytes
during the pachytene stage and is therefore used as a marker for pachytene within the field of
reproduction (Grive et al., 2016). However, until now, the majority of research conducted
investigating SYCP3 has used chromosome spreads to visualize individual cells. Chromosome
spreads involve the destruction of an ovary and the compression of cells in order to isolate single
germ cells. The characterization of SYCP3 in whole mount ovaries through
immunohistochemistry can provide a larger scale representation of the protein throughout the
entire ovary and can then be used as a tool by creating an expression profile in a normal ovary
that can be used for baseline comparisons. Therefore, further investigation of a variety of factors
that may influence germ cell development either negatively, such as exogenous hormones that
disrupt cyst breakdown, or positively, such as the addition of KIT ligand to promote cyst
breakdown, can be performed.
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Specific Aims
Current methods used to stage and analyze female germ cell development are tedious,
time consuming, and often do not allow researchers to gain an understanding of the ovary as a
whole. Present methods include hematoxylin and eosin (H&E) staining that requires the
mounting, sectioning (through slicing), and staining of the ovary and chromosome spreads,
which we described above. Both of these methods deconstruct the ovary and require extensive
protocols in order to complete. Given the importance of female infertility research, it is vital to
help improve research techniques that will provide more information at a more time effective
pace. The goals of my research are to use MSY2 expression levels and SYCP3 expression
pattern in whole mount immunohistochemistry as tools to analyze meiotic progression and to
determine the effects of estrogen and progesterone on meiotic progression analyzed by MSY2
protein levels and SYCP3 expression.
The specific aims for this thesis are:
1. Use MSY2 expression levels and SYCP3 expression pattern in whole mount
immunohistochemistry as tools to analyze meiotic progression.
2. Determine the effects of estrogen and progesterone on meiotic progression analyzed by
MSY2 protein levels and SYCP3 expression.
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Chapter 2: MATERIALS AND METHODS
Animal Model
The mouse model used in this research is the inbreed strain C57BL/6J. Males and
females are caged separately with two to five individual animals per cage until ready to breed.
The animals are kept on a 14 hour light/10 hour dark cycle. The cages are changed once a week
to provide fresh food, water, and bedding. All work done has been approved by the Institutional
Animal Care and Use Committee (IACUC).

Checking Vaginal Plugs and Staging Mouse Development
After male and female mice are placed together in a cage, females are checked for
vaginal plugs for the following four days. To check for a vaginal plug, females are raised from
the tail end and, using a pair of forceps, the vagina is slightly opened and inspected. If a female
has a small white bump consisting of coagulated secretions from the coagulating and vesicular
glands of the male inside of the vaginal opening, she is considered plugged (pregnant), separated
into her own cage, and is expected to give birth 19 days later. If on day five the female is still not
plugged, she is considered a no plug female and separated into her own cage and observed for
the next 19 days to make sure she is not pregnant.
Animals are staged by their plug date. Therefore, when a female is found to be plugged,
she is considered to be 0.5 dpc. A total of 19 days are counted out following the plug date and
that is considered the expected delivery date (19.5 dpc or PND1). Using this timeline, the age of
the pups can be determined.
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Ovary Harvesting
Ovaries were harvested from wildtype C57BL/6J pups at multiple time points during
development. Harvested ovaries ranged in development from 13.5 dpc to PND5. In order to
harvest ovaries from embryos (13.5 dpc to 18.5 dpc), mothers were sacrificed via CO2
asphyxiation and embryos were removed from the mother. Postnatal pups (PND1 to PND5) were
collected from animal cages housed with mothers. All pups were sacrificed via decapitation as
stated in the lab’s animal protocol. Once pups were sacrificed, ovaries were harvested from
female pups, excess tissue surrounding the ovaries was removed, and the ovaries were placed
into the proper solution depending on the protocol. When sacrificing mothers for the collection
of embryos, a maximum of two adult females were sacrificed at a time in order to avoid the
degradation of essential proteins before ovaries could be collected. When sacrificing postnatal
pups, a maximum of four pups were sacrificed at a time, also to avoid the degradation of
essential proteins.

Whole Mount Immunohistochemistry
Once ovaries were harvested, they were placed into 5.3% formaldehyde to fix the tissue
(16% EM grade formaldehyde diluted in 1X PBS). Ovaries were fixed overnight at 4°C on a
nutator. After fixation, ovaries went through a series of washes at room temperature in 0.1%
Triton X-100 in 1X PBS (PT) and PT + 5% bovine serum albumin (BSA). Following the washes,
the ovaries were incubated overnight with primary antibodies at varying concentrations in PT +
5% BSA at 4°C. Primary antibodies are listed in Table 1.
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Table 1. Primary Antibodies Used for Immunohistochemistry
Primary
Antibody
MSY2 (C-15)

Company

Catalog #

Species Made In

Dilution
1:100

Mouse

1:200

Rabbit

1:500

Rat

1:500

VASA

Abcam

sc-21316
Lot #: C0615
sc-74569
Lot #: J1314
sc-482
Lot #: I0613
73-003
Lot #: 141113A
ab-13840
Lot #:
GR172688-1

Goat

TRA98

Santa Cruz
Biotechnology
Santa Cruz
Biotechnology
Santa Cruz
Biotechnology
B-Bridge

Rabbit

1:250

SYCP3 (D-1)
STAT3 (C-20)

After overnight incubation in primary antibody, ovaries went through another series of washes
including: PT + 1% BSA for 30 minutes, RNase A (10 µl of 10 mg/ml RNase A in 1 ml PT + 1%
BSA) for 30 minutes, propidium iodide (10 µl of 0.5 mg/ml in 1 ml PT + 1% BSA) or TOTO3
(Molecular Probes; 1:2000 dilution in PT + 1% BSA) for 20 minutes in the dark (samples
remained in dark environment after this wash), and one more wash in PT + 1% BSA for 30
minutes. RNase A was used to degrade any residual single stranded RNA present in the sample
in order to eliminate potential background staining in the cytoplasm. Propidium iodide or
TOTO3 was used to label the nuclei of all cells present in the sample. Ovaries were then
incubated with pre-absorbed secondary antibodies overnight at 4°C in order to eliminate any
nonspecific staining. Negative controls using only the secondary antibody were previously tested
in the lab for all antibodies used. Secondary antibodies were pre-absorbed using a small amount
of embryo powder overnight at 4°C. Secondary antibodies used are listed in Table 2. The
embryo powder was prepared from 14.5 dpc embryos by taking whole embryos, dehydrating
them, and grinding them down to a powder.
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Table 2. Secondary Antibodies Used for Immunohistochemistry
Secondary Antibody
Alexa Fluor 488
Donkey Anti-Goat
Alexa Fluor 488
Donkey Anti-Mouse
Alexa Fluor 488
Donkey Anti-Rabbit
Alexa Fluor 488
Donkey Anti-Rat
Alexa Fluor 488
Goat Anti-Mouse
Alexa Fluor 488
Goat Anti-Rabbit
Alexa Fluor 488
Rabbit Anti-Goat
Alexa Fluor 568
Donkey Anti-Goat
Alexa Fluor 568
Donkey Anti-Rabbit
Alexa Fluor 568
Goat Anti-Mouse

Company
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen
Molecular
Probes/Invitrogen

Catalog #
A11055

Species Made In
Donkey

Dilution
1:200

A21202

Donkey

1:200

A21206

Donkey

1:200

A21208

Donkey

1:200

A11029

Goat

1:200

A11008

Goat

1:200

A11078

Rabbit

1:200

A11057

Donkey

1:200

A10042

Donkey

1:200

A11004

Goat

1:200

Secondary antibodies were used at a 1:200 dilution in PT + 5% BSA. Following overnight
incubation, ovaries were washed in PT + 1% BSA at room temperature three times for 30
minutes each. Ovaries were then quickly rinsed in PBS, placed in vectashield to prevent fading,
and mounted onto large cover slips.

Fluorescent Microscopy
Ovaries were fixed and stained through immunohistochemistry as described in the
previous section. After ovaries were stained, they were imaged through fluorescent microscopy
on the confocal microscope (Zeiss LSM 710 System with an Axio Observer). In order to create
an MSY2 expression pattern profile, ovaries were viewed under 63X magnification and the
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“field of most oocytes” was located. A single image for each ovary was captured and scored to
create the profile. For each ovary, an expression pattern profile was also created for SYCP3 by
viewing the ovaries under 63X magnification and taking two cores of four images each, with the
images separated by 20 microns. In order to score ovaries treated in organ culture, z-stacks were
created under 63X magnification as well. Stacks consisted of 11 images, each one micron apart,
surrounding each center image (Figure 3).

Figure 3
Schematic showing method in which ovaries were analyzed through confocal microscopy.
Each ovary was analyzed by taking 2 cores of 4 images each 20 µm apart. Around each
image, a stack of 11 images (5 above and 5 below) each 1 µm apart was taken.

Analysis of Meiotic Progression
Ovaries at multiple stages of development were imaged on the confocal microscope and
then manually counted. A series of images were taken for each ovary (as explained in previous
section) in order to gain a complete representation of the protein expression in the ovary (Figure
3). The images were then processed by examining all of the oocytes present in each section and
14

analyzing each ovary in several categories. For distinguishing oocytes reaching and arresting at
the diplotene stage, the following categories were scored: oocyte number, number of oocytes
strongly expressing MSY2 protein, oocytes weakly expressing MSY2 protein, and oocytes not
expressing MSY2 protein. To distinguish oocytes reaching the pachytene stage, the expression
pattern of SYCP3 was analyzed over a series of developmental stages and the number of oocytes
displaying the pattern of expression congruent with pachytene were counted.

In vitro Ovary Organ Culture
Ovaries for in vitro ovarian organ culture were harvested from 17.5 dpc embryos. The
ovaries were harvested in petri dishes filled with Hank’s Balanced Salt Solution. Once the
ovaries were dissected from the pups and all excess tissue was removed, the ovaries were
transferred onto a filter located in a six-well tissue culture plate kept on ice. Directly before
adding the ovaries to the filter, 1.0 ml of cold Hank’s Balanced Salt Solution was added to the
well. A total of two ovaries were added to each filter in each well, leaving a maximum of 12
ovaries possible per plate. After all ovaries were harvested and transferred onto their filter, the
filters were then transferred to a new sterile six-well tissue culture plate under a sterile hood.
After transferring filters to a new sterile plate, 1.2 ml of warm stock culture media was
added to each well under a sterile hood. The media was warmed in a water bath set to 37°C. The
stock culture media was prepared using the following solutions: L-ascorbic acid (0.05 mg/ml in
DMEM), 10% Albumax stock, 7.5% BSA, penicillin/streptomycin, and DMEM complete media
(Invitrogen). The tissue culture plate was then placed in a sterile incubator pre-set at 37°C and
5% CO2 for one hour to acclimate the ovaries. Following the hour acclimation period, the media
was removed from each well and 1.2 ml of fresh media is added. At this point, the stock culture
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media was replaced with treatment media. Treatments included: estradiol (β-estradiol ≥98%;
Sigma E8875) (10-6 M in DMSO), progesterone (progesterone ≥99%; Sigma P0130) (10-6 M in
DMSO), and estradiol & progesterone (10-6 M in DMSO for both). Vehicle controls using
DMSO were also included in the treatments (0.001% DMSO and 0.002% DMSO). Once the
treatment media was added, tissue culture plates were placed back into the incubator for 22 to 26
hours. Treatment was replaced in the same manner for the following three days and then
terminated on the fifth day.
In order to terminate the organ culture, media was removed from each well and replaced
and washed with warm Hank’s Balanced Salt Solution. Once rinsed, ovaries were removed from
the filters and placed into fixative (5.3% formaldehyde in 1X PBS) overnight at 4°C. Ovaries
were then stained with MSY2, SYCP3, TRA98, VASA, TOTO3, or PI (or combination of
multiple antibodies) as described earlier in the immunohistochemistry section.

Analysis of Oocyte Development and Cyst Breakdown
After ovary samples were collected, treated in organ culture, stained through
immunohistochemistry, and imaged through confocal microscopy, as described in previous
sections, the ovaries were scored for the following categories: oocyte number, cyst breakdown,
follicle development, and meiotic progression. A total of eight images per ovary and a total of
eight ovaries per developmental stage were scored and averaged together. Oocyte number was
collected by counting the total number of visible oocytes that were present within the field of the
image. More than 50% of the nucleus had to be within the field of view in order to be scored.
Cyst breakdown was analyzed by scoring the number of single oocytes versus the number of
oocytes still in cysts. The numbers were converted into percentages and averaged. In order to
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distinguish the different stages of follicle development, follicles were observed and scored based
on the developmental status. Follicles were either scored as primordial, germ cell surrounded by
flattened granulosa cells, primary, germ cell surrounded by a layer of cuboidal granulosa cells, or
secondary, germ cell surround by multiple layers of cuboidal granulosa cells. Finally, the
oocytes were scored for meiotic progression through the analysis of either MSY2 (diplotene) or
SYCP3 (pachytene). Expression of either MSY2 or SYCP3 was analyzed and counted to
determine the meiotic staging of each oocyte.

Statistical Analysis
Unpaired, two-tailed t-tests were performed to analyze the effects of hormone treatments
through organ culture on oocyte number, cyst breakdown, follicle development, and meiotic
progression. T-tests were performed through Microsoft Excel 2013 with a p<0.05 considered as
significant.
One-way ANOVA’s were performed to analyze the difference in expression of meiotic
markers MSY2 and SYCP3 across the developmental timeline, variance between pairs of ovaries
of littermates, and the difference between in vivo and in vitro ovarian samples. GraphPad PRISM
statistical software was used to perform ANOVA’s with Bonferroni’s (<5 groups) and NewmanKeuls (≥5 groups) Multiple Comparison posttests indicating p<0.05 as significant.
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Chapter 3: RESULTS
MSY2 Expression Correlates with Diplotene Arrest
In order to follow and stage meiotic progression, specific meiotic markers were chosen to
create expression profiles. First, MSY2 expression was used to identify oocytes at the diplotene
stage of meiotic prophase I. MSY2 expression was analyzed within the female germ cells over
the developmental period starting from 15.5 dpc through PND 5. Each oocyte was counted and
marked as either strongly expressing or weakly expressing MSY2 (Figure 4). Strong expression
of MSY2 within an oocyte indicates that the cell has reached and arrested at the diplotene stage
of meiotic prophase I. Asymmetric expression of MSY2 was observed within the same ovarian
cysts in multiple confocal sections.

Figure 4
Asymmetric expression of MSY2 protein in wildtype ovaries. Image shown is a confocal
microscope section from a PND1 wildtype ovary. (A) MSY2 expression labeled in green. (B)
Nuclei of all cells labeled with propidium iodide in red. (C) Overlay of both MSY2 (green)
and propidium iodide (red) channels. Asterisk indicates an oocyte strongly expressing MSY2.
Square indicates an oocyte with weak MSY2 expression. The arrow and arrowhead are
showing an example of asymmetric expression of MSY2 within the same cyst. The arrow
indicates an oocyte with weak MSY2 expression within the cyst and the arrowhead indicates
an oocyte with strong MSY2 expression within that same cyst. Scale bar = 20 µm.
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Once all sections were counted and analyzed for MSY2 expression, an expression profile was
created for the developmental stages of 15.5 dpc through PND5 (Figure 5). Strong expression of
MSY2 was seen to be at ~40% as early as 15.5 dpc and the percent of germ cells strongly
expressing MSY2 increased over the developmental time points. At PND5, almost all (~94%)
oocytes were strongly expressing MSY2. The increase in oocytes strongly expressing MSY2
correlates with expected increase in oocytes arriving at and arresting at the diplotene stage of
meiotic prophase I.

Figure 5
MSY2 expression correlates with the progression of oocyte development to the diplotene
stage of meiotic prophase I. Percent of oocytes with strong MSY2 labeling in ovaries (+/SEM) from 15.5 dpc through PND5. Different letters indicate a significant difference between
groups (P<0.05; n = 8 ovaries per developmental stage) as determined by a one-way ANOVA
followed by Newman-Keuls multiple comparisons test.
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SYCP3 Expression Correlates with the Pachytene Stage of Meiotic Prophase I
A second expression profile, using SYCP3, was created to follow and stage meiotic
progression. SYCP3 expression was analyzed within the female germ cells over the
developmental period starting from 13.5 dpc through PND 5. Each oocyte was analyzed through
the SYCP3 expression pattern to be either in the pachytene stage of meiotic prophase I or not
(Figure 6). Expression of SYCP3 in the pachytene stage is found as condensed “strings”
between homologous chromosomes.

Figure 6
Confocal microscope section showing expression pattern of SYCP3 in PND1 wildtype ovary.
(A) SYCP3 expression labeled in green. (B) Nuclei of all cells labeled with propidium iodide
in red. (C) Overlay of both SYCP3 (green) and propidium iodide (red) channels. Circled
oocytes show expression pattern of SYCP3 in pre/post pachytene stage. Arrowhead is
showing expression pattern of SYCP3 in an oocyte in the pachytene stage. Scale bar = 20 µm.

After the number of pachytene staged oocytes was counted, a profile was created
reporting the percent of oocytes observed in pachytene (Figure 7). Oocytes in the pachytene
stage were not seen until 16.5 dpc. After 16.5 dpc, an increase in the number of pachytene
labeled oocytes increased until PND1 where a peak of ~55% was seen. Starting at PND2, the
number of oocytes at the pachytene stage significantly decreased and no cells were observed to
be in pachytene after PND3.
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Figure 7
Percent of oocytes in the pachytene stage of development in ovaries from 13.5 dpc through
PND5. Staging of oocytes determined through SYCP3 expression pattern (+/-SEM). Different
letters indicate a significant difference between groups (P<0.05; n = 8 ovaries per
developmental stage) as determined by a one-way ANOVA followed by Newman-Keuls
multiple comparisons test.

Examining the Effects of Steroid Hormones on Meiotic Progression by Analysis of a
Diplotene Arrest Marker
The effects of exogenous hormone exposure on cyst breakdown, follicle formation, and
meiotic progression of developing ovaries was tested through treatment of estradiol and/or
progesterone. 17.5 dpc ovaries were harvested and grown in vitro using an organ culture system.
Ovaries were grown for five days (four 24 hour periods) in various treatment groups (0.001%
DMSO vehicle, 0.002% DMSO, 10-6 M estradiol, 10-6 M progesterone, and 10-6 M estradiol +
progesterone) until they reached PND3 (Figure 8A). Once at PND3, ovaries were fixed and
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stained with MSY2 and TRA98 (germ cell marker) through immunohistochemistry and then
analyzed through confocal microscopy (Figure 8B). Analysis was done by taking two cores of
four images as explained in the previous section (Figure 3).

Figure 8
Organ culture with hormone treatment analyzed by MSY2 expression experimental set up.
(A) Timeline of organ culture experiment procedure. (B) Representative confocal section
labeled with MSY2 (red), TRA98, oocyte marker (green), and TOTO3, nuclear marker (blue).
Oocytes marked as strong (S), weak (W), or no (N) expression. Scale bar = 20 µm.

Once imaged through confocal microscopy, ovaries were analyzed for oocyte number,
cyst breakdown, follicle development, and meiotic progression. Estradiol and progesterone
appeared to have no effect on oocyte number or follicle development (Figure 9A and 9C).
However, the treatments of estradiol alone and estradiol with progesterone did significantly
disrupt cyst breakdown and decrease the percent of single oocytes in each section (Figure 9B).
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Figure 9
Effects of estradiol and progesterone on oocyte development in organ culture examining
diplotene arrest from first series of organ culture experiments. (A) Number of oocytes per
confocal section after 5 days in culture with varying treatments (+/-SEM). (B) Percent single
oocytes after 5 days in culture with varying treatments (+/-SEM). Asterisk indicates
significant difference from control (P<0.05) as determined by a two-tailed T-test. (C) Percent
of follicles at different stages of development after 5 days in culture with varying treatments.
n = 8 ovaries per treatment group. Three replicates were performed.
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Following the in vitro organ culture experiment, oocytes were marked as either
expressing MSY2 strongly, weakly, or not at all in order to analyze the effects of hormone
exposure on meiotic progression. Progesterone significantly lowered the percent of oocytes
strongly expressing MSY2 and significantly increased the percent of oocytes with no MSY2
expression (Figure 10). Estradiol as well as both hormones together did not have a significant
impact on MSY2 expression.

Figure 10
Progesterone but not estradiol reduces MSY2 expression. Graph showing the percentage of
oocytes expressing MSY2 strongly, weakly or not at all (+/-SEM). Asterisk indicates
significant difference from control (P<0.05; n = 8 ovaries per treatment group) as determined
by a two-tailed T-test.
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Examining the Effects of Steroid Hormones on Meiotic Progression by Analysis of
Pachytene Oocytes
Another set of in vitro organ culture experiments were conducted using the same protocol
as previously described in order to analyze the effects of exogenous hormone exposure on
developing ovaries using a marker for the pachytene stage. Again, 17.5 dpc ovaries were
harvested and grown in vitro using an organ culture system. Ovaries were grown for five days
(four 24 hour periods) in various treatment groups (0.001% DMSO vehicle, 0.002% DMSO, 10-6
M estradiol, 10-6 M progesterone, and 10-6 M estradiol and progesterone) until they reached
PND3 (Figure 11A). Once at PND3, ovaries were fixed and stained with SYCP3 and VASA
(germ cell marker) through immunohistochemistry and then analyzed through confocal
microscopy (Figure 11B). Ovaries were analyzed with the same protocol (Figure 3).

Figure 11
Organ culture with hormone treatment analyzed by SYCP3 expression experimental set up.
(A) Timeline of organ culture experiment procedure. (B) Representative confocal section
labeled with VASA, oocyte marker (red), SYCP3 (green), and TOTO3, nuclear marker (blue)
showing pachytene expression pattern. Scale bar = 20 µm.
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Neither estradiol nor progesterone were seen to have an effect on cyst breakdown or
follicle development in the second series of organ culture experiments, but treatment with both
estradiol and progesterone did significantly decrease the number of oocytes per section (Figure
12). When results are compared to in vivo data of the same developmental stage, there appears to
be a promotion of development in ovaries in vitro. Number of oocytes per section is reduced and
the percent of single oocytes is increased in vitro when compared to in vivo.
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Figure 12
Effects of estradiol and progesterone on oocyte development in organ culture examining germ
cell progression to the pachytene stage from second series of organ culture experiments. (A)
Number of oocytes per confocal section after 5 days in culture with varying treatments (+/SEM). Asterisk indicates significant difference from control (P<0.05) as determined by a twotailed T-test. (B) Percent single oocytes after 5 days in culture with varying treatments (+/SEM). (C) Percent of follicles at different stages of development after 5 days in culture with
varying treatments. n = 8 ovaries per treatment group. Three replicates were performed.
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Following the second set of in vitro organ culture experiments, oocytes were labeled with
SYCP3 and marked as either in pachytene or pre/post pachytene in order to analyze the effects of
hormone exposure on an earlier stage of meiotic progression. Ovaries treated with estradiol and
progesterone together had a significant increase in the percent of oocytes in the pachytene stage
suggesting that progression through meiotic prophase I was delayed (Figure 13).

Figure 13
Estradiol and progesterone have a combined effect on the number of oocytes at pachytene.
(A) Graph showing the percentage of oocytes in the pachytene stage as determined by SYCP3
expression pattern (+/-SEM). Asterisk indicates significant difference from control (P<0.05; n
= 8 ovaries per treatment group) as determined by a two-tailed T-test.
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No Variance Observed Between Pairs of Ovaries from Litter Mates
In order to further justify the results achieved and check for any potential error in
experimental procedure, variance between pairs of ovaries from PND1 litter mates was analyzed.
Ovaries are normally pooled together from litter mates when conducting experiments creating
one set of data. There was no variance observed in the number of oocytes per section, cyst
breakdown, or follicle development between pairs of ovaries from litter mates. No significant
difference between pairs was observed in the average number of oocytes per section, the average
percent of single oocytes, or the average percent of follicles at different developmental stages
(Figure 14).
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Figure 14
No significant variance is observed between pairs of ovaries from individuals within the same
litter. (A) Number of oocytes per confocal section in separate pairs of ovaries (+/-SEM). (B)
Percent single oocytes in separate pairs of ovaries (+/-SEM). (C) Percent of follicles at
different stages of development in separate pairs of ovaries (+/-SEM).
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Estradiol Confirmed to Disrupt Cyst Breakdown in Later Stage Ovaries
Previous studies found estradiol to disrupt cyst breakdown and follicle formation to a
more substantial degree when conducting organ culture experiments starting with PND1 ovaries
compared to current experiments starting at 17.5 dpc (Chen et al., 2007). Verification of previous
results was needed in order to determine if the lesser effect was due to a change in experimental
design or because of researcher error in performing experiments. Confirmation of results was
achieved through an organ culture experiment starting with PND1 ovaries and growing them in
vitro for five days to reach PND5 (Figure 15A). Treatment with estradiol (10-6 M in DMSO)
disrupted cyst breakdown and follicle formation (Figure 15B).

Figure 15
Estradiol disrupts cyst breakdown in PND1 ovaries cultured for 5 days. (A) Timeline showing
treatment process of organ culture experiment. (B) Representative confocal sections of PND5
vehicle control and estradiol treated ovaries. Ovaries were fixed and stained with MSY2 (red),
TRA98, oocyte marker (green), and TOTO3, nuclear marker (blue). Scale bars = 20 µm.
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When analyzed through confocal microscopy, there was a significant decrease in the number of
oocytes per section and in the percent of single oocytes, but no significant change in follicle
development (Figure 16A-C). When looking at the effect on meiotic progression through MSY2
analysis, a significant increase in the number of oocytes not expressing MSY2 at all was
observed suggesting a potential delay in meiotic progression (Figure 16D).

Figure 16
Estradiol reduces the number of oocytes, disrupts cyst breakdown, and delays meiotic
progression in PND1 ovaries cultured for 5 days. (A) Number of oocytes per confocal section
-6

after 5 days in culture with 10 M estradiol (+/-SEM). (B) Percent single oocytes after 5 days
-6

in culture with 10 M estradiol (+/-SEM). (C) Percent of follicles at different developmental
-6

stages after 5 days in culture with 10 M estradiol. (D) Percent of oocytes expressing MSY2
-6

strongly, weakly or not at all after 5 days in culture with 10 M estradiol (+/-SEM). Asterisk
indicates significant difference from control (P<0.05; n = 8 ovaries per treatment group) as
determined by a two-tailed T-test.
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Organ Culture System has a Negative Effect on Ovarian Health
To determine any potential negative effects the organ culture system or the vehicle
control of DMSO may have had on ovarian health, comparisons of treatment groups and in vivo
ovaries of the same age were observed. When comparing in vivo control, in vitro control, and in
vitro DMSO treated ovaries, there is only a significant difference observed between the in vivo
and in vitro groups. Ovaries grown in an organ culture system have a significantly lower number
of oocytes per section and higher percent of single oocytes with no change in follicle
development (Figure 17A-C). Analysis of meiotic progression using MSY2 expression only
showed a difference in the in vitro control with a significant decrease in the percent of oocytes
strongly expressing MSY2 and a significant increase in the percent of oocytes not expressing
MSY2 at all, suggesting the organ culture system significantly delays the progression of oocytes
through meiosis (Figure 17D).
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Figure 17
DMSO does not have a negative effect on ovaries, but organ culture system shows a negative
effect on ovarian health. (A) Number of oocytes per confocal section both in vivo and after 5
days in culture with varying treatments (+/-SEM). (B) Percent single oocytes both in vivo and
after 5 days in culture with varying treatments (+/-SEM). (C) Percent of follicles at different
developmental stages both in vivo and after 5 days in culture with varying treatments. (D)
Percent of oocytes expressing MSY2 strongly, weakly or not at all both in vivo and after 5
days in culture with varying treatments (+/-SEM). Different letters indicate a significant
difference between groups (P<0.05; n = 8 ovaries per treatment group) as determined by a
one-way ANOVA followed by Bonferroni’s multiple comparisons test.
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Chapter 4: DISCUSSION
Whole mount immunohistochemistry of ovarian samples was successfully used to
characterize progression of female germ cells through meiotic prophase I. MSY2, a germ cell
specific maternal mRNA binding protein, has been shown to be upregulated in oocytes reaching
and arresting at the diplotene stage (Gu et al., 1998). The use of MSY2 as a marker for diplotene
arrest was shown through the analysis of YBX2 mRNA (bovine MSY2), which showed an
increase of mRNA expression in primordial follicles advancing to primary follicles with oocytes
at the diplotene stage (Yang and Fortune, 2008). It was also originally found and then further
confirmed that oocytes begin to enter diplotene arrest at 17.5 dpc. In order to link MSY2
expression with diplotene arrest, MSY2 mRNA levels were analyzed across the developmental
period from 13.5 dpc through PND5 and it was shown that MSY2 expression does not
significantly increase until 18.5 dpc which correlates with the timing of diplotene arrest (Dutta
and Pepling, unpublished). However, in the present experiments, when looking at the MSY2
characterization through whole mount antibody staining, it was shown that at 15.5 dpc, 41% of
oocytes were already strongly expressing MSY2. This level of expression is much higher than
expected given that diplotene arrested oocytes were not even present until 17.5 dpc and MSY2
mRNA expression did not increase until 18.5 dpc. The expression of MSY2 did increase over
development correlating with the idea of MSY2 upregulation during diplotene arrest beginning
with the first significant increase at PND1, and almost all oocytes strongly expressing MSY2 by
PND5 (94%). This finding suggests that MSY2 is not actually a marker for diplotene arrest, but
rather its increase in expression over the developmental time period correlates with progression
of oocytes to the diplotene stage. SYCP3, a protein found in SCs, is involved with chromosome
pairing and recombination (Meuwissen et al., 1992). This protein has been widely used in the

35

field of reproduction as a marker for meiotic prophase due to its distinct expression pattern
during the pachytene stage (Grive et al., 2016). However, most work looks at the expression of
SYCP3 at the cellular level and not in whole mount. Through whole mount antibody staining of
ovarian samples, I established that the highest percentage of oocytes found in pachytene was
54% at PND1, which then significantly decreased to 12% at PND2 (Figure 7). This result
correlates with previous work showing the temporal expression pattern of the pachytene stage
(Borum, 1961).
It should be noted that when imaging ovaries that were stained through
immunohistochemistry through confocal microscopy, the intensity of the laser did not remain
constant for each image taken. When moving deeper into the ovary, the intensity of the laser
needed to be increased in order to visualize the staining of the protein. Laser intensities were
observed and there was no significant change of laser intensity variance from one developmental
age to the next.
Previous research has shown that estrogens and progesterone have negative effects on the
development process of female germ cells. Progesterone and estradiol, phytoestrogen genistein,
as well as synthetic estrogens all disrupt cyst breakdown and follicle formation (Chen et al.,
2007; Jefferson et al., 2006; Karavan and Pepling, 2012) thereby leading to a potential decrease
in viable egg cells later in life. In some instances, the number of oocytes present was also
affected, but not as consistently. In the work presented in this thesis, two series of organ cultures
were completed, each treating ovaries with either estradiol (10-6 M), progesterone (10-6 M), or
estradiol and progesterone (10-6 M) with little to no effect on cyst breakdown and follicle
formation. In the first series of organ cultures, no effect was seen on oocyte number or follicle
development, but there was a small but significant decrease in the percent of single oocytes in
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both the estradiol alone and estradiol + progesterone groups indicating a disruption of cyst
breakdown. In the second series, there was no significant effect on the percent of single oocytes
or follicle development, but there was a significant decrease in the number of oocytes in the
estradiol + progesterone treatment group. Similar results were expected for each set of
experiments and the difference in results could be due to a lower average number of oocytes
present in the second series of organ cultures. Also, even though there was a significant
disruption of cyst breakdown in some of the treatment groups of the first series, the result was
much less severe than previously reported. The studies conducted prior to these organ culture
experiments were initiated on PND1 ovaries, whereas the current studies were started earlier
with 17.5 dpc ovary samples. This earlier starting point may be out of the window of sensitivity,
which would lead to little or no visible effects (Dutta et al., 2016). Also, when comparing in vivo
ovaries similar in developmental age to ovaries treated through organ culture, there does appear
to be a noticeable decrease in the number of oocytes and increase in the percent of single oocytes
suggesting either an unfavorable organ culture system environment or a potential acceleration of
development caused by the organ culture system.
Another aspect of the organ culture experiments that was analyzed was the effects of
estrogen and progesterone on meiotic progression. Again, two series of organ cultures were
completed with the first series being labeled for MSY2, marker for diplotene, and the second
series being labeled with SYCP3, marker for pachytene. Previous research has shown that when
pregnant female mice were exposed to Bisphenol A (BPA), an estrogenic chemical, meiotic
progression was disrupted by way of a disturbance of the synapsis and recombination of
chromosome homologs (Susiarjo et al., 2007). When PND1 ovaries of rats were treated with
estradiol in an organ culture system, primordial follicle assembly was slightly delayed and
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transition from primordial to primary follicles was inhibited showing a disruption in
development (Kezele and Skinner, 2003). However, the major finding was actually that
progesterone showed a much stronger effect on follicle assembly. Another study showed that
progesterone acts through the progesterone receptor membrane component 1 (PGRMC1) to
significantly delay or completely disrupt meiotic progression and therefore disrupt primordial
follicle assembly (Guo et al., 2016). The results of my organ culture series agreed with these
findings. In the first series of cultures, strong MSY2 expression (marking cells arrested at
diplotene) was significantly decreased in only the progesterone treatment and the oocytes not
expressing MSY2 at all was significantly increased in both the estradiol treatment and the
progesterone treatment indicating a delay in meiotic progression. In the second series, the
number of oocytes found in the pachytene stage significantly increased only in the estradiol +
progesterone treatment group indicating that treatment with both hormones delayed meiotic
progression.
Given some of the unexpected results discovered during the organ culture experiments, it
was vital to check a number of different potential causes of error including the use of different
littermates across litters and the impact of comparing developmental processes using explanted
ovaries into organ cultures and ovaries harvested from whole animals.
Data collected for organ culture experiments came from pools of ovaries that were
combined from multiple different litters. Checking for any variance between ovary pairs of
different individuals from the same litter would eliminate the possibility of skewed data if no
variance was found. Three pairs of ovaries were compared against each other with no variance
found justifying the pooling of ovaries from multiple individuals.
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Moreover, the effects of estradiol treatments at 10-6 M on ovaries through an organ
culture system had been shown to significantly lower the percent of single oocytes and delay the
progression of follicle development while having no effect on the number of oocytes (Chen et
al., 2007). Since the effect seen in organ culture here was less severe and the only difference
from previous work was the age of the ovary when it entered culture (PND1 vs 17.5 dpc), we
repeated the organ culture to confirm that estradiol would block cyst breakdown if started at
PND1. Results were only partially replicated with a significant decrease in the percent of single
oocytes (though much less severe than the published studies from our lab). The number of
oocytes present was significantly decreased in my experiment and also the follicle development
was not significantly decreased. We went a step further and looked at the effect of estradiol on
meiotic progression through the analysis of MSY2 expression and found that there was a
significant increase in the number of oocytes not expressing MSY2 at all which would indicate a
delay in meiotic progression. The result combined with the positive result of cyst breakdown
disruption indicates that there is no issue with the estradiol. However, the significant decrease in
number of oocytes present within the ovary leads to the assumption that there may be an issue
with the organ culture system and its ability to maintain the health of the ovaries during culture
experiments. Previous studies have shown that when working with a slightly different organ
culture system, ovaries treated for seven days with estradiol and progesterone had no visible
decline in oocyte number (Chen et al., 2007) and ovaries treated with genistein even had an
increase in oocyte number (Jefferson et al., 2006), further confirming this assumption. Finally,
the addition of DMSO to the media (solvent for estradiol) could have potential negative effects
on ovarian health. Comparing DMSO vehicle controls to an organ culture control and an in vivo
control would indicate any potential harmful effects of the DMSO. When looking at oocyte
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number, percent single oocytes, and follicle development, there was no significant difference
between DMSO vehicle controls and the organ culture control indicating that the DMSO did not
have any detrimental effects. However, all three organ culture controls (two DMSO vehicle
controls and organ culture control) were significantly different from the in vivo control in all
three categories. This again indicates a potential problem with the organ culture system itself and
its maintenance of ovarian health. Also, when looking at the effects on meiotic progression
through analysis of MSY2 expression, the only group to be significantly different was the organ
culture control (significant decrease in percent of oocytes strongly expressing MSY2 and
significant increase in the number of oocytes not expressing MSY2 at all).
In summary, protein characterization of female germ cells through whole mount
immunohistochemistry is a powerful tool for the field of reproduction and allows researchers to
gain a complete picture of the ovary and its development. Researchers can visualize the
expression of the protein of interest while also getting a clear picture of ovarian development
through analysis of cyst breakdown, follicle formation, follicular development, and meiotic
progression. Using this technique, characterization of two meiotic markers, MSY2 and SYCP3,
was completed and can now be used to analyze the effects of other pathways involved with germ
cell development, such as KIT signaling, or environmental factors, such as BPA and other
endocrine disrupters. Here these two protein profiles were used to analyze the effects of
exogenous hormone exposure and it was determined that estradiol and progesterone disrupt cyst
breakdown and that progesterone significantly delays/disrupts meiotic progression of female
germ cells.
In the future, work needs to be done investigating the organ culture system used in order
to further optimize growing conditions and improve ovarian health while in the system. Once the
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system is optimized, treatments of estradiol and progesterone should be repeated to confirm
findings. Also, further investigation into the pathway that progesterone is acting on is required in
order to better understand the effects of progesterone specifically on meiotic progression of
female germ cells. Finally, with the use of the protein characterization profiles created here,
further investigation into other pathways and environmental factors that may affect cyst
breakdown and follicle formation can be completed through the use of the organ culture system
and then analyzed with the profiles.
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APPENDIX 1:
Arrest at the diplotene stage of meiotic prophase I is delayed by progesterone but is not
required for primordial follicle formation in mice
Sudipta Dutta1,2, Deion Burks1, and Melissa Pepling1*

In order to assist in the research investigating diplotene arrest and the effects of steroid
hormones on meiotic progression, I imaged and analyzed hematoxylin and eosin (H&E) stained
ovarian sections and counted them for the number of oocytes found to be in the diplotene stage,
the number oocytes found to be in pre-diplotene stages, and the percent of oocytes found to be in
follicles for PND3, 4, and 5. Images of H&E sections taken by myself were used for Figure 3
(see attached article). Data collected for PND3, 4, and 5 were used in graphs for Figures 1 and 2
(see attached article).
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